£1,000
No changevs May 2024Active - Proposal to Strike off04217081Private limited companyLondon
BIOPHARMA DEVELOPMENT LTD
D43/100Proposal to strike offThe registrar has published a notice proposing to remove this company from the register. Unless the cause is dealt with or an objection is upheld, it can be dissolved.
01
Summary
BIOPHARMA DEVELOPMENT LTD is an active (proposal to strike off) private limited company (company number 04217081) incorporated on 15 May 2001, registered in London. Its registered activity is activities of other holding companies n.e.c. (SIC 64209). Latest dormant accounts cover the period ending 31 May 2025, showing net assets of £1,000. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the upper half of 11,452 comparable companies in London (median £100, upper quartile £78k).
02
Key dates
- Incorporated
- 15 May 200125 yrs ago
- Next accounts due
- 28 February 2027in 129 days
- Confirmation statement due
- 29 May 2027in 219 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 64209
- Activities of other holding companies n.e.c.
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
04
Financials
Not reported
Not reported
Not reported
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | £1,000 | — | — | — | — | — | — |
| 31 May 2024 | £1,000 | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
05
Firmoscan score
43 / 100 · grade D
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £1,000 at 2025-05-31 |
| +8 | EstablishedIncorporated 2001-05-15 (25 years) |
| −25 | Status not ActiveActive - Proposal to Strike off |
| 43 | Score, grade D |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Mr Yury Belokon
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Confirmation statement duein 219 days
- Next accounts duein 129 days
- Accounts period endNet assets £1,000 · dormant accounts
- Accounts period endNet assets £1,000 · dormant accounts
- Incorporated
08
Similar companies in London
- HEDGETON LIMITEDLondon · inc. May 2001
- HOLDINVEST LATINAMERICA LTDLondon · inc. May 2001
- YI-QUAN INVESTMENTS LIMITEDLondon · inc. May 2001
- PRIOR I.T. EUROPE LTDLondon · inc. May 2001
- ENRICHMENT INVESTMENTS LIMITEDLondon · inc. May 2001
- GHG INTERMEDIATE HOLDINGS LIMITEDLondon · inc. May 2001
All companies incorporated on 15 May 2001 · in May 2001.
09
Reminders for BIOPHARMA DEVELOPMENT LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.